Postpartum depression has several effective treatments, ranging from a new 14-day oral medication to standard antidepressants, therapy, and supportive lifestyle changes. The right option depends on how severe your symptoms are, whether you’re breastfeeding, and how quickly you need relief. Most people with PPD improve significantly with treatment, and the earlier you start, the better the outcomes tend to be.
First, a quick distinction worth knowing: the “baby blues” typically start within two to three days of delivery and resolve within two weeks. If your mood symptoms last beyond that two-week mark, or feel intense enough to interfere with daily life or bonding with your baby, that points toward postpartum depression, which can develop anytime in the first year after birth.
Zuranolone: The First Oral Medication for PPD
In 2023, the FDA approved zuranolone (brand name Zurzuvae), the first pill specifically designed for postpartum depression. It works differently from traditional antidepressants. Instead of targeting serotonin, it acts on a brain signaling system involved in the hormonal shifts that happen after delivery. The treatment course is short: one 50 mg pill taken each evening with a fatty meal for 14 days. That’s it.
In two clinical trials, women taking zuranolone showed significantly greater improvement in depressive symptoms compared to placebo by day 15. The benefit held up four weeks after stopping the medication, meaning the effects lasted well beyond the two-week course. This speed is a major advantage, since traditional antidepressants often take weeks to kick in. The most common side effects are drowsiness, dizziness, and the common cold. You shouldn’t drive or operate heavy machinery for at least 12 hours after taking a dose.
One limitation: zuranolone’s safety during breastfeeding hasn’t been well studied yet, so this is a conversation to have with your provider if nursing is important to you.
SSRIs and Traditional Antidepressants
For moderate to severe PPD, selective serotonin reuptake inhibitors remain the most commonly prescribed medications. Sertraline has the strongest evidence base for postpartum depression specifically. These medications typically take three to four weeks to produce noticeable improvement, which can feel like a long wait when you’re struggling, but they’re well studied, widely available, and relatively affordable.
If you’re breastfeeding, sertraline and paroxetine are generally considered the safest choices. Both transfer into breast milk at very low levels, with a relative infant dose of only 0.5% to 3%. For context, anything under 10% is considered acceptable. By comparison, some other antidepressants like fluoxetine and citalopram get closer to that 10% threshold.
One finding worth noting: in one study, antidepressants showed significant symptom improvement at four weeks postpartum, but by 18 weeks there was no meaningful difference between women who took medication and those who received supportive counseling alone. This doesn’t mean antidepressants don’t work. It suggests that for some women, they’re most valuable in that acute early phase when symptoms are worst, and that therapy can be equally powerful over time.
Therapy That Works for PPD
Two types of talk therapy have the best evidence for postpartum depression: cognitive behavioral therapy (CBT) and interpersonal therapy (IPT). CBT helps you identify and reshape negative thought patterns, which is particularly useful for the guilt, self-doubt, and catastrophic thinking that often come with PPD. IPT focuses on relationship dynamics and role transitions, which makes it a natural fit for the enormous identity shift of new parenthood.
Response rates for therapy are high. In one study comparing therapy-based treatment to medication, nearly 79% of women in the combined therapy group showed significant improvement. Therapy can be used on its own for mild to moderate PPD or alongside medication for more severe cases. Many providers now offer virtual sessions, which removes the logistical barrier of getting to an office with a newborn.
The IV Infusion Option
Before zuranolone, the FDA approved brexanolone (Zulresso) in 2019 as the first medication specifically for PPD. It works on the same brain pathway as zuranolone but is given as a continuous IV infusion over 60 hours (two and a half days) in a certified healthcare facility. A provider must be on site for the entire infusion, and you’re monitored with a pulse oximeter because of the risk of sudden excessive sedation or loss of consciousness, which occurred in about 4% of patients in clinical trials.
Because of these safety requirements, you must stay in a medical facility for the full treatment. You also need to be accompanied during any interactions with your baby. Brexanolone is effective and fast-acting, but the practical demands, safety monitoring, and cost (often tens of thousands of dollars) mean it’s typically reserved for severe cases where other options haven’t worked or aren’t fast enough.
Exercise and When to Start
Physical activity is one of the most accessible tools for managing PPD symptoms, and the data is encouraging. Postpartum exercise is associated with 40% lower odds of developing postpartum depression compared to being sedentary. The research shows a dose-response effect: more exercise volume correlates with greater reductions in symptom severity.
Timing matters, though. Starting exercise before 12 weeks postpartum showed a statistically significant reduction in depressive symptom severity, while starting after 12 weeks did not produce the same benefit. This doesn’t mean exercise is useless after three months. It means the earlier you can incorporate even light activity, the better. Studies used sessions ranging from 15 to 30 minutes, one to five days per week, involving aerobic activity, strength training, or even stretching. You don’t need to run a 5K. A daily 20-minute walk with the stroller counts.
Vitamin D and Omega-3s
Low vitamin D levels show a clear association with PPD risk. Women with vitamin D below 20 ng/mL were 3.3 times more likely to have postpartum depression compared to women with levels above that threshold. Over half of women with PPD in one study had levels below 20 ng/mL, compared to about a third of women without depression. If you haven’t had your vitamin D checked recently, it’s a simple blood test. Many postpartum women are deficient, especially those who had limited sun exposure during pregnancy or who have darker skin.
Omega-3 fatty acids, particularly EPA and DHA found in fish oil, have gotten attention as a potential PPD treatment, but the evidence is mixed. An early pilot study found that EPA-dominant fish oil (at doses of 0.5 to 2.8 grams per day for eight weeks) reduced depressive symptoms, and higher doses seemed to work better. However, a rigorous placebo-controlled trial found no additional benefit from omega-3 supplements when women were already receiving therapy. Studies using DHA alone at lower doses (200 to 220 mg per day) also failed to prevent postpartum depressive symptoms. Omega-3s are safe and have other health benefits for both you and your baby, but they shouldn’t be relied on as a standalone treatment for PPD.
Combining Treatments
PPD responds best when you layer approaches rather than relying on a single one. A common and effective combination is an SSRI to stabilize your mood in the short term, therapy to build coping skills and address underlying patterns, and basic lifestyle supports like regular movement, adequate nutrition, and sleep whenever possible (which, with a newborn, often means accepting help so you can rest during the day).
Zuranolone’s 14-day course can also serve as a bridge, providing rapid relief while a longer-term antidepressant builds up in your system or while you establish a rhythm with therapy. The key takeaway is that postpartum depression is highly treatable, and the range of options now available means there’s likely a combination that fits your specific situation, preferences, and breastfeeding goals.